12 results
Keyword Blinatumomab Remove keyword
Type of content
News Remove News filter
-
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 November 2018
CHMP, Last updated: 16/11/2018blinatumomab) in patients with residual … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 September 2018
CHMP, Last updated: 21/09/2018blinatumomab … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 July 2018
CHMP, Last updated: 27/07/2018of medicine Blincyto INN blinatumomab Marketing-authorisation holder … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 September 2015
CHMP, Last updated: 25/09/2015blinatumomab) for the treatment of Philadelphia … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2020
CHMP, Last updated: 16/10/2020Blincyto INN blinatumomab Marketing-authorisation holder … -
List item
Press release: Conditional marketing authorisations give patients access to important new medicines earlier
Last updated: 23/01/2017 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 11-14 January 2021
PRAC, Last updated: 15/01/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 February 2021
PRAC, Last updated: 12/02/2021 -
List item
News: EMA 2017 annual report published
Last updated: 02/05/2018 -
List item
News: Progress in science, medicine and health
Last updated: 17/05/2016 -
List item
News: Progress on science, medicines and health
Last updated: 10/05/2017 -
List item
News: Annual report 2009 published: "Agency achieved very good results in one of the most challenging years in its history"
Last updated: 20/05/2010